Buffalo, NY, United States of America

Kelvin Lee

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Centro De Inmunologia Molecular, Innovative Immunotherapy Alliance, S.A.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kelvin Lee. Retrieved from https://idiyas.com/inventor/kelvin-lee-5plkiupp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kelvin Lee - Innovator in Therapeutic Compositions

Introduction

Kelvin Lee is a notable inventor based in Buffalo, NY (US). He has made significant contributions to the field of therapeutic compositions, particularly in the treatment of tumors of epithelial origin. His innovative work has led to the development of a patent that addresses critical medical challenges.

Latest Patents

Kelvin Lee holds a patent titled "Use of Therapeutic Compositions for the Treatment of Patients with Tumors of Epithelial Origin." This patent represents a significant advancement in cancer treatment, showcasing his dedication to improving patient outcomes through innovative solutions. He has 1 patent to his name.

Career Highlights

Throughout his career, Kelvin has worked with various organizations that focus on immunotherapy and cancer research. Notably, he has been associated with Innovative Immunotherapy Alliance, S.A. and Centro De Inmunologia Molecular. His experience in these companies has allowed him to collaborate with leading experts in the field.

Collaborations

Kelvin Lee has collaborated with Tania Crombet Ramos, a fellow professional in the field. Their partnership has contributed to advancements in therapeutic strategies and has furthered research in cancer treatment.

Conclusion

Kelvin Lee's contributions to the field of therapeutic compositions highlight his commitment to innovation and improving healthcare. His work continues to inspire future advancements in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…